Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Department of Immunology, University of Washington, Seattle, Washington, USA.
J Orthop Res. 2023 May;41(5):942-950. doi: 10.1002/jor.25453. Epub 2022 Oct 26.
Anti-inflammatory Regulatory T cells (Tregs) are enriched in the joints of patients with osteoarthritis (OA) compared to healthy joints. Tregs maintain homeostasis through secretion of anti-inflammatory cytokines and cell-to-cell interactions including immune checkpoint signaling. Interleukin-6 (IL-6) is a pleiotropic cytokine secreted by inflamed synoviocytes and chondrocytes that can inhibit or alter Treg function. This study tested the hypothesis that neutralization of IL-6 would enable Treg anti-inflammatory function to resolve inflammation and catabolism elicited by IL-1β in an equine chondrocyte/synoviocyte/Treg tri-culture OA model. Synoviocyte/chondrocyte co-cultures were stimulated with IL-1β, and treated with αIL-6 neutralizing antibody. Activated Tregs secreting IL-10 were added in direct contact with synoviocytes to create a tri-culture. Neutralization of IL-6 partially restored Treg anti-inflammatory functions and, in combination, reduced IL-1β-stimulated synoviocyte MMP13 expression to control levels and restored Acan expression in chondrocytes. IL-6 neutralization alone decreased Il6 expression in chondrocytes and synoviocytes, mitigating IL-6 positive feedback loop. Although Tregs were the primary producers of anti-inflammatory IL-10 and IL-4, they also produced pro-inflammatory IL-17A, as detected by ELIA, which may have been responsible for incomplete rescue of synoviocyte/chondrocyte homeostasis following IL-1β stimulation. Treg secretion of IL-10, IL-4, and IL-17A was not altered by tri-culture conditions or presence of αIL-6, therefore, it was unlikely that Treg phenotype instability occurred. The significant effect of chondrocyte/synoviocyte donor, but not Treg donor, on gene expression and IL-6 concentration in conditioned media, indicated that personalized therapy considering the patient's OA status might be needed for successful implementation of immunotherapy in the context of OA.
与健康关节相比,骨关节炎(OA)患者的关节中富含抗炎调节性 T 细胞(Tregs)。Tregs 通过分泌抗炎细胞因子和细胞间相互作用(包括免疫检查点信号)来维持内稳态。白细胞介素-6(IL-6)是一种由炎症性滑膜细胞和成纤维细胞分泌的多效细胞因子,可抑制或改变 Treg 的功能。本研究旨在验证以下假设:中和 IL-6 将使 Treg 的抗炎功能能够在马软骨细胞/滑膜细胞/Treg 三培养 OA 模型中消除由 IL-1β 引发的炎症和分解代谢。用 IL-1β 刺激滑膜细胞/软骨细胞共培养物,并使用 αIL-6 中和抗体进行处理。将分泌 IL-10 的活化 Tregs 直接与滑膜细胞接触以创建三培养物。中和 IL-6 部分恢复了 Treg 的抗炎功能,并且与联合使用时,将 IL-1β 刺激的滑膜细胞 MMP13 表达降低至对照水平,并恢复了软骨细胞中的 Acan 表达。单独中和 IL-6 可降低软骨细胞和滑膜细胞中的 Il6 表达,减轻了 IL-6 的正反馈环。尽管 Tregs 是抗炎性 IL-10 和 IL-4 的主要产生者,但它们也产生了促炎性 IL-17A,这是通过 ELIA 检测到的,这可能是导致在 IL-1β 刺激后,滑膜细胞/软骨细胞的内稳态不能完全恢复的原因。三培养条件或存在 αIL-6 并未改变 Treg 分泌的 IL-10、IL-4 和 IL-17A,因此,Treg 表型不稳定不太可能发生。软骨细胞/滑膜细胞供体而不是 Treg 供体对基因表达和条件培养基中 IL-6 浓度的显著影响表明,考虑到患者的 OA 状态,可能需要个性化治疗,以便在 OA 背景下成功实施免疫疗法。